FierceBiotech
@FierceBiotech
The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.
加入 December 2008
615 正在關注 102.7K 粉絲
Atsena Therapeutics has reported evidence of efficacy in a clinical trial of an eye disease gene therapy, encouraging the biotech to forge ahead with a study that could support a filing for approval in 2028.
顯示更多
